MAXIFLOX TAB
Each film-coated tablet contains: Moxifloxacin Hydrochloride equivalent to Moxifloxacin 400 mg
| Composition | Each film-coated tablet contains: Moxifloxacin Hydrochloride equivalent to Moxifloxacin 400 mg |
| Packing | BLISTER - 5*10 tablets |
| MRP | ₹138 |
Product Overview
MAXIFLOX TAB is a highly potent, advanced fourth-generation fluoroquinolone antibiotic indicated for the treatment of severe bacterial infections. Its extended spectrum provides excellent coverage against Gram-positive, Gram-negative, atypical, and anaerobic pathogens, ensuring rapid clinical resolution.
Indications
This broad-spectrum antibiotic is clinically indicated for:
- Acute Bacterial Sinusitis: Eradicates resistant upper respiratory pathogens.
- Acute Bacterial Exacerbation of Chronic Bronchitis: Provides swift resolution of lower respiratory tract flare-ups.
- Community-Acquired Pneumonia: Targets multi-drug-resistant strains of Streptococcus pneumoniae and atypical bacteria.
- Complicated Skin and Skin Structure Infections: Treats deep tissue infections requiring optimal tissue penetration.
Dosage & Administration
The recommended dosage is one 400 mg tablet taken orally once daily. The duration of therapy typically ranges from 5 to 21 days, depending on the severity and site of the infection. Tablets can be taken with or without food and must be swallowed whole with a full glass of water.
Adverse Effects
Commonly reported adverse drug reactions include:
- Nausea, diarrhea, and abdominal pain
- Dizziness or mild headaches
- Transient elevations in liver transaminase enzymes
View Complete Medical Information
Contraindications
Contraindicated in patients with a history of hypersensitivity to moxifloxacin or other fluoroquinolones. Do not prescribe to individuals with pre-existing QT interval prolongation, uncorrected hypokalemia, or a clinical history of tendon disorders associated with fluoroquinolone therapy.
Warnings & Precautions
Fluoroquinolones are associated with serious risks, including tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. Discontinue treatment immediately if tendon pain, inflammation, or neurological symptoms occur. Use with caution in patients with known central nervous system disorders that may predispose them to seizures.
Drug Interactions
Co-administration with antacids, multivitamins, or supplements containing magnesium, aluminum, iron, or zinc significantly impairs oral moxifloxacin absorption; these should be taken at least 4 hours before or 8 hours after the antibiotic. Concurrent use with Class IA or Class III antiarrhythmic agents increases the risk of dangerous QT prolongation.
Storage Instructions
Store below 30°C in a dry place. Keep the tablets inside their blister packaging until use to protect them from ambient moisture.
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the ANTIBIOTIC therapeutic category
I CEF 1.5 INJ
Composition:Each vial contains: Ceftriaxone 1000mg Sulbactam 500mg
VIAL WITH SWFI AND CARTON - 1 VialPack Style: Vial
I TRANS 4.5 INJ
Composition:Each vial contains: Piperacillin 4 gm Tazobactam 0.5 gm
VIAL WITH SWFI - 1 VialPack Style: Vial
CIANCLAV 625 TAB [NEW]
Each film coated tablet contains : Amoxicillin Trihydrate IP Eq. to Amoxicillin 500mg Potassium Clavulanate IP (As Potasssium Clavulanate Diluted IP) Eq. to Clavulanic Acid 125mg
ALU ALU IN MONOCARTON & SHRINK - 10*1*10
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.